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This study aimed to clarify the association between depressive symptoms and a marker of oxidative 
stress-induced DNA damage in young females.  Since the menstrual cycle may confound or modify this 
association,  depressive symptoms and urinary levels of 8-hydroxy-2ʼ deoxyguanosine (8-OHdG) were 
evaluated during each menstrual phase.  A total of 57 female fourth-year students (aged 21.6±0.8) 
from a Japanese health science university were studied.  The menstrual cycle was divided into 3 
phases: menstrual (days 1 to 3 after the onset of menses); proliferative (days 13 to 15); and secretory 
(days 24 to 26).  Depressive symptoms were assessed by the self-rating depression scale (SDS).  Positive 
depressive symptoms were deﬁned as a score of 53 or more during 2 diﬀerent menstrual phases.  The 
association between the presence of depressive symptoms and 8-OHdG levels adjusting for the men-
strual cycle was examined by two-way analysis of variance with the menstrual cycle (menstrual,  pro-
liferative,  and secretory phases) as the within-individual factor.  The menstrual cycle did not show a 
signiﬁcant correlation with urinary 8-OHdG levels.  On the other hand,  the menstrual cycle-adjusted 
8-OHdG level was signiﬁcantly higher in those with depressive symptoms (7.01ng/mL) than in those 
without them (3.98ng/mL).  The ROC curve analysis showed that urinary 8-OHdG levels had reason-
ably high discriminative performance throughout all the menstrual cycles (0.73-0.81; all p＜0.05).  
These results indicated the presence of oxidative stress in subjects with depressive symptoms indepen-
dent of the menstrual cycle.
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here is a growing interest in establishing physi-
ological indices related to depression.  Several 
biomarkers have been shown to be relevant to depres-
sion,  including C-reactive protein,  cytokines,  neop-
terin,  malondialdehyde,  8-hydroxy-2ʼ deoxyguanosine 
and isoprostanes (for review see [1]).  Recently,  an 
association was reported between depression and uri-
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nary 8-OHdG levels,  a marker of oxidative stress to 
DNA.  Ishihara et al.  examined the association between 
the prevalence of depression and urinary 8-OHdG 
levels in female nurses,  and reported that urinary 
8-OHdG levels were higher in depressive nurses [2].  
Similarly,  in a study conducted by Forlenza et al.  
involving 169 youths (32 males and 137 females),  the 
depressive group showed signiﬁcantly higher serum 
8-OHdG levels than the control group,  independently 
of sex and age [3].  On the other hand,  in a study 
conducted by Yi et al.  involving 210 female workers,  
no signiﬁcant correlation was observed between 
depressive symptoms and urinary 8-OHdG levels [4].  
In short,  inconsistencies exist regarding the associa-
tion between depression and 8-OHdG levels.  One of 
the explanations may be that in these previous studies,  
the menstrual cycle was not examined despite its pos-
sible inﬂuences on the association between depression 
and oxidative stress markers.  In fact,  Matsumoto et al.  
compared the urinary 8-OHdG levels of 205 female 
workers during diﬀerent menstrual phases,  and found 
that the levels tended to increase during the prolifera-
tive phase,  although the diﬀerence was not statisti-
cally signiﬁcant [5].  On the other hand,  it has been 
reported that 20ｵ to 50ｵ of healthy females experi-
ence mental symptoms such as depressed feelings,  
anxiety,  and restlessness 7 to 10 days before the 
onset of menses [8].  We previously reported that 
stress inﬂuenced the secretion of female hormones 
during menstruation [6],  that anxiety symptoms 
appeared before menstruation in females with depres-
sion,  and that the anxiety symptoms were correlated 
with the urinary 8-OHdG and serum serotonin 
(s-serotonin) levels [7].  This correlation should be 
investigated further,  with consideration paid to varia-
tion in the acceptance of stress among individuals and 
individualsʼ uniformity.  However,  few studies have 
evaluated stress/stress response biofactors with 
respect to the menstrual cycle,  or investigated the 
association between anxiety,  which is characteristic of 
depressive symptoms,  and stress response biofactors.  
Depending on the ﬁndings of such analyses,  it might 
be necessary to consider the menstrual cycle when 
examining the association between depression and 
urinary 8-OHdG levels in females.
　 Therefore,  this study examined the association 
between depression and urinary 8-OHdG levels while 
taking the menstrual cycle into consideration.
Materials and Methods
　 Participants. Volunteers who self-reported 
having normal menstrual cycles were recruited.  
Among 60 fourth-year female students of a Japanese 
health science university who were provided with suf-
ﬁcient explanations regarding the studyʼs objective and 
methods,  58 consented to participate.  Informed con-
sent was acquired from all the participants in written 
form.  One student whose menstrual cycle did not meet 
the inclusion range of 26 to 37 days was excluded,  
leaving 57 students in the ﬁnal study group [9,  10].  
This study was conducted in accordance with the 
Helsinki Declaration with the approval of the Ethics 
Committee of Fujita Health University (approval 
number: 10-075).
　 Study items. This study was conducted from 
June to September 2009.  Participantsʼ menstrual 
cycles were self-reported during the study period,  and 
were divided into 3 phases: menstrual (days 1 to 3 
after the onset of menses); proliferative (days 13 to 
15); and secretory phase (days 24 to 26).  self-rating 
depression scale (SDS) scores and urinary samples 
were evaluated during each phase.
　 Deﬁnition of depressive symptoms. Those 
with an SDS score of 53 or more were deﬁned as 
having depressive symptoms [11].  According to the 
deﬁnition of a major depressive episode in the DSM-IV,  
which requires the presence of symptoms lasting for 
at least 2 weeks [12],  we considered those who had 
an SDS score of 53 or more during 2 diﬀerent men-
strual phases to be depressive,  and considered the 
remaining participants as normal in the present study.  
The SDS and collection of urinary samples each 
menstrual phase were performed between 12 : 00 and 
13 : 00 before lunch.
　 Measurement of urinary 8-OHdG levels.
The collected urinary samples were extracted between 
12 : 00 and 13 : 00 before lunch in consideration of the 
daily ﬂuctuation of each menstrual phase.  Oral reports 
were checked on the day before each collection,  and 
collections were omitted on the days following an 
intense menstrual ﬂow.  The collected urinary samples 
were centrifuged at 1,500 rounds per minute for 
5min,  and the supernatant was stored in a freezer at 
－20 degrees Celsius until analysis.  The urinary 
8-OHdG was measured in triplicate (8-OHdG Check 
Kit; Japan Institute for the Control of Aging 
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(JaICA); R2＝0.92-0.96 and CV＝0.021-0.023).
　 Data analysis. The association between 
depression and 8-OHdG levels was examined by partial 
correlation analysis with adjustment for age and BMI.  
In addition,  the association between depression and 
8-OHdG levels was examined by a two-way analysis of 
variance with the presence/absence of depression and 
the menstrual cycle (menstrual,  proliferative,  and 
secretory phases) as factors,  and urinary 8-OHdG 
levels as the dependent variable.  A histogram and 
Kolmogorov-Smirnov test (p＝0.200) were used to 
conﬁrm that the urinary 8-OHdG levels were in the 
normal range.  In addition,  an area under the ROC 
curve (AUC) analysis was performed to determine the 
overall accuracy of 8-OHdG as an index of the pres-
ence/absence of depression in each of the 3 phases.  
Analysis was performed using SPSS 21.0 J (IBM 
Japan,  Tokyo,  Japan),  and the signiﬁcance level was 
set at p＜0.05.
Results
　 No signiﬁcant diﬀerences in age,  height,  or body 
weight were observed between the depressive and 
normal groups (Table 1).  SDS scores did not vary 
signiﬁcantly with the 3 menstrual phases in either 
group.  SDS showed the subjects which was a high 
value about each menstrual phases and 2 or more time 
of them.  (Table 2).  The subjects who the SDS by the 
classiﬁcation of menstrual phases was a high value did 
not vary.
　 Partial correlation analysis of the relation between 
urinary 8-OHdG levels and the SDS scores adjusted 
for age and BMI revealed a signiﬁcantly positive cor-
relation between the 2 parameters in each of the 
menstrual phases (Table 3).  Similarly,  there were no 
signiﬁcant diﬀerences in urinary 8-OHdG levels by the 
menstrual phases in either group (Fig.  1; p＝0.529,  
p for interaction＝0.863).  On the other hand,  the mean 
urinary 8-OHdG level adjusted for the menstrual cycle 
was signiﬁcantly higher in the depressive group 
(7.01ng/mL) compared to the normal group (3.98ng/mL) 
(p＝0.040).
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Table 1　 Age,  anthropometric variables,  and SDS scores in the Normal and Depressive Groups
Normal (n＝47) Depressive (n＝10)
Mean SD Mean SD p
Age (years)  21.5 0.7  22.0 0.9 0.050
Height (cm) 158.6 4.6 160.1 5.1 0.361
Body weight (kg)  51.2 6.3  49.1 4.8 0.325
BMI (kg/cm2)  20.3 2.3  19.1 1.3 0.118
SDS Menstrual phase  42.2 6.2  55.1 4.2 ＜0.001
Proliferative phase  41.9 5.7   †  52.3 9.2   ‡ ＜0.001
Secretory phase  41.4 5.7  52.9 7.8 ＜0.001
One-factor repeated measures analysis of variance: † p＝0.865,  ‡ p＝0.361
SD,  standard deviation; BMI,  body mass index; SDS,  self-rating depression scale.
Table 2　 Characteristics of the subjects of the Normal (SDS＜




Menstrual phase 49 8
Proliferative phase 50 7
Secretory phase 48 9
Combination of menstrual and proliferative phases 55 2
Combination of proliferative and secretory phases 55 2
Combination of menstrual and secretory phases 54 3
Combination of all phases 54 3
SDS,  self-rating depression scale: ＜53,  SDS scale is less than 
53 scores: 53≦,  SDS scale is 53 or more scores.
Table 3　 Relationship between the urinary 8-OHdG levels and 
SDS scores by menstrual phase (adjusted for age and BMI)
Partial correlation coeﬃcient p value
Menstrual phase 0.563 0.012
Proliferative phase 0.472 0.041
Secretory phase 0.56 0.013
partial correlation coeﬃcient: adjusted for the age and BMI
　 The AUC was 0.81 (p＝0.005) during the men-
strual,  0.73 (p＝0.038) during the proliferative,  and 
0.80 (p＝0.006) during the secretory phases (Fig.  2).
Discussion
　 Urinary 8-OHdG levels were signiﬁcantly higher in 
the depressive group independent of the menstrual 
cycle,  and partial correlation analysis between uri-
nary 8-OHdG levels and the SDS scores revealed a 
signiﬁcant positive correlation in each menstrual phase;  
these ﬁndings were consistent with the previous stud-
ies [1,  3].  This is,  to our knowledge,  the ﬁrst study 
on the relation between urinary 8-OhdG and depres-
sion to take the menstrual cycle into account.  An 
increased reactive oxygen level due to psychological 
stress [13,  14] might have led to an increase in the 
urinary 8-OHdG level [15].  Indeed,  reactive oxygen 
species (ROS) are produced in response to the secre-
tion and decomposition of stress hormones,  and spe-
ciﬁcally of adrenocortical hormones [16].  In addition,  
large amounts of vitamin C are consumed under stress 
as antioxidants [17],  and this process is generally 
thought to lead  to a further increase of ROS.  Further,  
reperfusion to tissues exposed to reduced blood ﬂow 
due to vasoconstriction caused by sympathetic nervous 
activation has been associated with increased produc-
tion of ROS [18-20].  Subjects with depressive 
symptoms have been reported to exhibit high suscepti-
bility to sympathetic nervous [21-25] and high sympa-
thetic nervous activity [26-28] in response to stress.  
The increase in ROS by the activated sympathetic 
nervous system might cause oxidative damage to the 
DNA of the person experiencing depressive symptoms.  
Alternatively,  slower recovery of lymphocyte DNA 
from X-ray-induced damage has been reported in 
depressive individuals compared to the healthy ones 
[29].  Although the present study was not carried out 
to identify mechanisms explaining the association 
between depression and urinary 8-OHdG levels,  it did 
reveal that those with depressive symptoms often have 
increased urinary 8-OHdG levels,  possibly due to 
increased ROS levels or slower recovery of DNA 
damage.  Forlenza et al.  examined the association 
between depression and serum 8-OHdG in 169 young 
persons (males/females) using covariance analysis and 
a trend test after dividing them into depression and 
comparison groups and adjusting the results by gender 
and age.  They reported that the mean serum 8-OHdG 
level was signiﬁcantly higher in the depression group 
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Fig. 2　 ROC Curve during Each Menstrual Phase.  The solid line 
shows the results for the menstrual phase,  the dashed line those for 
the proliferative phase,  and the dotted line those for the secretory 
phase.  The AUCs (SDs) and p-values in each phase were 0.81 
(0.07),  0.005 (menstrual); 0.73 (0.90),  0.038 (proliferative); and 
0.80 (0.72),  0.006 (secretory),  respectively.
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Fig. 1　 Comparison of Urinary 8-OHdG Levels between the 
Normal and Depressive Symptoms by Menstrual Phases.  The solid 
line indicates the results for normal individuals,  the dotted line the 
results for individuals with depressive symptoms.  Two-way factorial 
analysis of variance with the presence/absence of depression and 
menstrual cycle as factors (adjusted for the age and BMI).
Depression: p＝0.040; menstrual cycle: p＝0.529; interaction:  
p＝0.863
Adjusted mean: depressive: 7.01ng/mL; normal: 3.98ng/mL.
[3].  Although our present results were limited to 
young women,  our ﬁndings were similar to those of the 
previous studies [3,  7],  and thus further clarify the 
association between depression and urinary 8-OHdG.  
In addition,  we found that these factors were not 
inﬂuenced by the menstrual cycle.  Therefore,  the 
results suggest that urinary 8-OHdG is useful for the 
early detection of depression in young women,  and that 
this parameter is not inﬂuenced by the menstrual 
cycle.  Based on previous studies [3,  7],  8-OHdG 
may be a depression-associated marker.  In addition,  
this tendency may be present not only in young females 
but also in those of other ages and males.  Based on the 
results of this study,  the use of urinary 8-OHdG for 
objective assessment along with SDS and other ques-
tionnaires for subjective assessment may contribute to 
the early detection of depression in young women and 
the arrangement of the lifestyle/environment/support 
system to assist persons with depressive symptoms in 
schools and workplaces.
　 There were several limitations in the present study.  
First,  our sample was limited to female students of a 
single university,  and thus it would be inappropriate 
to generalize the ﬁndings,  although the participantsʼ 
height and weight were similar to those of a Japanese 
national survey [30].  In addition,  the studentsʼ life-
styles were likely to be uniform,  unlike lifestyles in 
the general population,  and while this homogeneity 
was likely to have contributed to the internal validity 
of the results,  it also make our ﬁndings less general-
izable.  Nonetheless,  the present ﬁndings clearly 
revealed a potential association between depression 
and premenstrual syndrome in the secretory phase.  
Second,  our participantsʼ smoking habits were self-
reported.  Although the participants were informed of 
the strict conﬁdentially of this study,  it is possible 
that some of them misreported.  In future studies,  it 
would be preferable to obtain urinary or salivary 
cotinine levels.  Third,  the collected urinary samples 
were extracted between 12 : 00 and 13 : 00 before 
lunch in consideration of daily ﬂuctuations in the levels 
of the parameters measured.  Since these samples 
were collected as spot urine samples,  in future it 
might be useful to add creatinine correction or gen-
eration speed correction.  Fourth,  we evaluated the 
presence of depressive symptom based only on SDS 
scores.  As there were no conﬁrmatory diagnoses from 
psychiatrists,  false-positive or -negative depression 
might have been present,  which could have distorted 
the association.  In an attempt to avoid systematic 
over- or under-diagnosis,  we performed sensitivity 
analyses by changing the cut-oﬀ point of the SDS 
score.  In comparison of the normal and the depressive 
which considered only in 1 time of a menstrual cycle 
as cutoﬀ of 53 (Studentʼs t-test),  the menstrual phases 
3 periods was that the depression was a high value 
(menstrual phase: normal,  4.1ng/mL; depressive,  
7.3ng/mL (p＝0.006); proliferative phase: normal,  
4.4ng/mL; depressive,  7.9ng/mL (p＝0.003); secre-
tory phase: normal,  3.8ng/mL; depressive,  6.8ng/mL 
(p＝0.016)).  Even when adopting a lower score of 40 
[31],  the depressive-group participants had higher 
urinary 8-OHdG levels (6.6ng/mL) than in the normal 
group (3.2ng/mL).  ROC curve analysis yielded simi-
lar results: the AUCs during the menstrual,  prolif-
erative,  and secretory phases were 0.73,  0.77,  and 
0.67,  respectively.  In future studies,  however,  it will 
be necessary to have depression evaluated by psychia-
trists.  In conclusion,  the results of this study con-
ﬁrmed that SDS scores are associated with urinary 
8-OHdG levels independent of the menstrual cycle.  
Although this study was cross sectional,  it would 
appear to suggest that young females with depressive 
symptoms are in a state of increased oxidative stress.
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